bioterrorism

The risks and benefits of influenza H5N1 research

Both Nature and the New York Times have weighed in on the resumption of influenza H5N1 research. In an editorial from 23 January 2013, Nature opines that “Experiments that make deadly pathogens more dangerous demand the utmost scrutiny”: As several critics point out, the assessments of the relative risks and benefits of such research remain …

The risks and benefits of influenza H5N1 research Read More »

Headline writers: Please take a virology course

Yesterday Denise Grady wrote in the New York Times about the end of the moratorium on influenza H5N1 virus research. The story headline read: Research to resume on modified, deadlier bird flu The Minneapolis Star Tribune reprinted Ms. Grady’s story with the following headline: Studies will resume on deadly modified flu virus Where do these …

Headline writers: Please take a virology course Read More »

End of moratorium on influenza H5N1 research

In early 2012 influenza virus researchers around the world decided to stop working on highly pathogenic avian influenza H5N1 virus. This decision came after work from the Fouchier and Kawaoka laboratories revealed the isolation of influenza H5N1 strains that can be passed among ferrets by aerosol. The moratorium on influenza H5N1 virus research has now …

End of moratorium on influenza H5N1 research Read More »

TWiV 200: Threading the NEIDL

On episode #200 of the science show This Week in Virology, Vincent, Alan, and Rich visit the National Emerging Infectious Diseases Laboratories at Boston University Medical Center, where they meet with Elke, Paul, and Ron to talk about building and working in a BSL4 facility. You can find TWiV #200 at www.microbe.tv/twiv.

Scroll to Top